These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20876772)

  • 81. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role of T and B cells in atherosclerosis: potential clinical implications.
    Dumitriu IE; Kaski JC
    Curr Pharm Des; 2011 Dec; 17(37):4159-71. PubMed ID: 22204376
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vaccination Strategies and Immune Modulation of Atherosclerosis.
    Nilsson J; Hansson GK
    Circ Res; 2020 Apr; 126(9):1281-1296. PubMed ID: 32324498
    [TBL] [Abstract][Full Text] [Related]  

  • 84. B-cell: a logical target for treatment of rheumatoid arthritis.
    Youinou P; Jamin C; Saraux A
    Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunity in Atherosclerosis: Focusing on T and B Cells.
    Poznyak AV; Bezsonov EE; Popkova TV; Starodubova AV; Orekhov AN
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445084
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
    van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
    Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
    [TBL] [Abstract][Full Text] [Related]  

  • 87. ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.
    Ley K; Gerdes N; Winkels H
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):764-777. PubMed ID: 28360089
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.
    Mohanta SK; Yin C; Peng L; Srikakulapu P; Bontha V; Hu D; Weih F; Weber C; Gerdes N; Habenicht AJ
    Circ Res; 2014 May; 114(11):1772-87. PubMed ID: 24855201
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [CD20 antibody for treatment of rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():544-8. PubMed ID: 15799415
    [No Abstract]   [Full Text] [Related]  

  • 91. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
    Björkbacka H; Fredrikson GN; Nilsson J
    Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The applications of anti-CD20 antibodies to treat various B cells disorders.
    Payandeh Z; Bahrami AA; Hoseinpoor R; Mortazavi Y; Rajabibazl M; Rahimpour A; Taromchi AH; Khalil S
    Biomed Pharmacother; 2019 Jan; 109():2415-2426. PubMed ID: 30551501
    [TBL] [Abstract][Full Text] [Related]  

  • 94. T-Cell/B-Cell Interactions in Atherosclerosis.
    Jones PW; Mallat Z; Nus M
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1502-1511. PubMed ID: 38813700
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Use of Mouse Models in Atherosclerosis Research.
    Getz GS; Reardon CA
    Methods Mol Biol; 2015; 1339():1-16. PubMed ID: 26445778
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
    Takasaki Y
    Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
    [No Abstract]   [Full Text] [Related]  

  • 97. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.